These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epidemiological profile and antifungal susceptibility pattern of Trichosporon species in a tertiary care hospital in Chandigarh, India. Mehta V, Chander J, Gulati N, Singla N, Vasdeva H, Sardana R, Kumar Pandey A. Curr Med Mycol; 2021 Mar; 7(1):19-24. PubMed ID: 34553093 [Abstract] [Full Text] [Related]
8. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen. Dabas Y, Xess I, Kale P. Med Mycol; 2017 Jul 01; 55(5):518-527. PubMed ID: 27816903 [Abstract] [Full Text] [Related]
9. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Tsai MS, Yang YL, Wang AH, Wang LS, Lu DC, Liou CH, Hsieh LY, Wu CJ, Cheng MF, Shi ZY, Lo HJ. Mycopathologia; 2012 Aug 01; 174(2):121-30. PubMed ID: 22318636 [Abstract] [Full Text] [Related]
17. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. Sun W, Su J, Xu S, Yan D. J Med Microbiol; 2012 Dec 01; 61(Pt 12):1750-1757. PubMed ID: 22956749 [Abstract] [Full Text] [Related]
18. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil. Menezes EA, Marinho JA, Angelo MR, Cunha Mda C, Cunha FA, Vasconcelos Júnior AA. Rev Inst Med Trop Sao Paulo; 2012 Dec 01; 54(1):1-3. PubMed ID: 22370746 [Abstract] [Full Text] [Related]